Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 8

1.

SMAD3 regulates gonadal tumorigenesis.

Li Q, Graff JM, O'Connor AE, Loveland KL, Matzuk MM.

Mol Endocrinol. 2007 Oct;21(10):2472-86. Epub 2007 Jun 26.

PMID:
17595316
2.

Genetic engineering to study testicular tumorigenesis.

Yan W, Burns KH, Matzuk MM.

APMIS. 2003 Jan;111(1):174-81; discussion 182-3. Review.

PMID:
12760377
3.

Transgenic models to study the roles of inhibins and activins in reproduction, oncogenesis, and development.

Matzuk MM, Kumar TR, Shou W, Coerver KA, Lau AL, Behringer RR, Finegold MJ.

Recent Prog Horm Res. 1996;51:123-54; discussion 155-7. Review.

PMID:
8701077
4.

Transgenic mouse models for gonadal tumorigenesis.

Rahman NA, Kananen Rilianawati K, Paukku T, Mikola M, Markkula M, Hämäläinen T, Huhtaniemi IT.

Mol Cell Endocrinol. 1998 Oct 25;145(1-2):167-74. Review.

PMID:
9922114
5.

Inhibin/activin and ovarian cancer.

Robertson DM, Burger HG, Fuller PJ.

Endocr Relat Cancer. 2004 Mar;11(1):35-49. Review.

6.

Mechanisms of inhibin signal transduction.

Bernard DJ, Chapman SC, Woodruff TK.

Recent Prog Horm Res. 2001;56:417-50. Review.

PMID:
11237224
7.

Inhibins/activins as diagnostic markers for ovarian cancer.

Robertson DM, Stephenson T, Pruysers E, Burger HG, McCloud P, Tsigos A, Groome N, Mamers P, McNeilage J, Jobling T, Healy D.

Mol Cell Endocrinol. 2002 May 31;191(1):97-103. Review.

PMID:
12044923
8.

Activins, inhibins, and follistatins: from endocrinology to signaling. A paradigm for the new millennium.

Welt C, Sidis Y, Keutmann H, Schneyer A.

Exp Biol Med (Maywood). 2002 Oct;227(9):724-52. Review.

PMID:
12324653

Supplemental Content

Support Center